{"entity":{"type":"insider","cik":"0001319763","url":"/insider/0001319763","json_url":"/insider/0001319763.json","name":"El Coronado Holdings, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":341,"n_filings":179,"first":"2005-03-04","last":"2014-02-13","span_basis":"filed_date"},"name_variants":[{"name":"El Coronado Holdings, LLC","source":"filing","n_filings":179,"first_seen":"2005-03-04","last_seen":"2014-02-13"}],"transactions":[{"id":6865321,"accession":"0001144204-14-008744","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-008744","line_url":"/filing/0001144204-14-008744","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Protea Biosciences Group, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":509168.0,"shares_display":"509,168","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":254584.0,"total_display":"254,584.00","total_whole":"254,584","shares_owned_after":6674725.0,"shares_owned_after_display":"6,674,725","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-30","filed_date":"2014-02-13","scope":"insider","n_lines":2},{"id":6773269,"accession":"0001144204-14-008789","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-008789","line_url":"/filing/0001144204-14-008789","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Protea Biosciences Group, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":509168.0,"shares_display":"509,168","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":254584.0,"total_display":"254,584.00","total_whole":"254,584","shares_owned_after":6674725.0,"shares_owned_after_display":"6,674,725","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-30","filed_date":"2014-02-13","scope":"insider","n_lines":2},{"id":5565003,"accession":"0001140361-13-040871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-040871","line_url":"/filing/0001140361-13-040871#line-2","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23922.0,"shares_display":"23,922","price_per_share":6.0066,"price_display":"6.01","price_state":"stated","total_value":143689.8852,"total_display":"143,689.89","total_whole":"143,690","shares_owned_after":385749.0,"shares_owned_after_display":"385,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-05","filed_date":"2013-11-06","scope":"insider"},{"id":5565001,"accession":"0001140361-13-040871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-040871","line_url":"/filing/0001140361-13-040871#line-1","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25400.0,"shares_display":"25,400","price_per_share":6.0249,"price_display":"6.02","price_state":"stated","total_value":153032.46,"total_display":"153,032.46","total_whole":"153,032","shares_owned_after":409671.0,"shares_owned_after_display":"409,671","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-04","filed_date":"2013-11-06","scope":"insider"},{"id":6865316,"accession":"0001144204-14-008744","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-008744","line_url":"/filing/0001144204-14-008744","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Protea Biosciences Group, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4743388.0,"shares_display":"4,743,388","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":2371694.0,"total_display":"2,371,694.00","total_whole":"2,371,694","shares_owned_after":5174558.0,"shares_owned_after_display":"5,174,558","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2014-02-13","scope":"insider","n_lines":8},{"id":6773262,"accession":"0001144204-14-008789","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-008789","line_url":"/filing/0001144204-14-008789","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Protea Biosciences Group, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4743388.0,"shares_display":"4,743,388","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":2371694.0,"total_display":"2,371,694.00","total_whole":"2,371,694","shares_owned_after":5174558.0,"shares_owned_after_display":"5,174,558","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2014-02-13","scope":"insider","n_lines":8},{"id":4582421,"accession":"0001140361-13-039799","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-13-039799","line_url":"/filing/0001140361-13-039799#line-3","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":6.037,"price_display":"6.04","price_state":"stated","total_value":6640.7,"total_display":"6,640.70","total_whole":"6,641","shares_owned_after":435071.0,"shares_owned_after_display":"435,071","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-29","scope":"insider"},{"id":4582415,"accession":"0001140361-13-039799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-039799","line_url":"/filing/0001140361-13-039799#line-2","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37409.0,"shares_display":"37,409","price_per_share":6.1813,"price_display":"6.18","price_state":"stated","total_value":231236.2517,"total_display":"231,236.25","total_whole":"231,236","shares_owned_after":436171.0,"shares_owned_after_display":"436,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-28","filed_date":"2013-10-29","scope":"insider"},{"id":4582411,"accession":"0001140361-13-039799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-039799","line_url":"/filing/0001140361-13-039799#line-1","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62591.0,"shares_display":"62,591","price_per_share":6.1724,"price_display":"6.17","price_state":"stated","total_value":386336.6884,"total_display":"386,336.69","total_whole":"386,337","shares_owned_after":473580.0,"shares_owned_after_display":"473,580","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-25","filed_date":"2013-10-29","scope":"insider"},{"id":4371091,"accession":"0001140361-13-038912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-038912","line_url":"/filing/0001140361-13-038912#line-1","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90025.0,"shares_display":"90,025","price_per_share":6.2117,"price_display":"6.21","price_state":"stated","total_value":559208.2925,"total_display":"559,208.29","total_whole":"559,208","shares_owned_after":536171.0,"shares_owned_after_display":"536,171","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4685876,"accession":"0001144204-13-051107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-051107","line_url":"/filing/0001144204-13-051107","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Protea Biosciences Group, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":524806.0,"shares_display":"524,806","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":262403.0,"total_display":"262,403.00","total_whole":"262,403","shares_owned_after":4048447.0,"shares_owned_after_display":"4,048,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-30","filed_date":"2013-09-16","scope":"insider","n_lines":2},{"id":5016053,"accession":"0001144204-13-034940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-034940","line_url":"/filing/0001144204-13-034940","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Protea Biosciences Group, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":560000.0,"shares_display":"560,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":280000.0,"total_display":"280,000.00","total_whole":"280,000","shares_owned_after":3786044.0,"shares_owned_after_display":"3,786,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-05","filed_date":"2013-06-14","scope":"insider","n_lines":2},{"id":4875192,"accession":"0001144204-13-017341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-017341","line_url":"/filing/0001144204-13-017341","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Protea Biosciences Group, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2740000.0,"shares_display":"2,740,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1370000.0,"total_display":"1,370,000.00","total_whole":"1,370,000","shares_owned_after":3506044.0,"shares_owned_after_display":"3,506,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-21","filed_date":"2013-03-25","scope":"insider","n_lines":2},{"id":5380179,"accession":"0000894579-13-000075","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000894579-13-000075","line_url":"/filing/0000894579-13-000075#line-7","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":626196.0,"shares_owned_after_display":"626,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-26","filed_date":"2013-02-27","scope":"insider"},{"id":5380176,"accession":"0000894579-13-000075","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000894579-13-000075","line_url":"/filing/0000894579-13-000075","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"NOVOGEN LTD","issuer_ticker":"NVGN","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Sponsored ADRs, each convertible into 25 ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":9.073333333333334,"price_display":"9.07","price_state":"stated","total_value":27220.0,"total_display":"27,220.00","total_whole":"27,220","shares_owned_after":627196.0,"shares_owned_after_display":"627,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-25","filed_date":"2013-02-27","scope":"insider","n_lines":6},{"id":9211003,"accession":"0000945621-12-000286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000945621-12-000286","line_url":"/filing/0000945621-12-000286#line-2","is_derivative":false,"issuer_cik":"0001319763","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001319763","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":439308.0,"shares_display":"439,308","price_per_share":0.9152,"price_display":"0.92","price_state":"stated","total_value":402054.6816,"total_display":"402,054.68","total_whole":"402,055","shares_owned_after":6432673.0,"shares_owned_after_display":"6,432,673","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-17","filed_date":"2012-12-19","scope":"insider"},{"id":3462893,"accession":"0000945621-12-000285","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000945621-12-000285","line_url":"/filing/0000945621-12-000285#line-2","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":439308.0,"shares_display":"439,308","price_per_share":0.9152,"price_display":"0.92","price_state":"stated","total_value":402054.6816,"total_display":"402,054.68","total_whole":"402,055","shares_owned_after":6432673.0,"shares_owned_after_display":"6,432,673","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-17","filed_date":"2012-12-18","scope":"insider"},{"id":9211002,"accession":"0000945621-12-000286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000945621-12-000286","line_url":"/filing/0000945621-12-000286#line-1","is_derivative":false,"issuer_cik":"0001319763","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001319763","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249249.0,"shares_display":"249,249","price_per_share":0.9501,"price_display":"0.95","price_state":"stated","total_value":236811.4749,"total_display":"236,811.47","total_whole":"236,811","shares_owned_after":6871981.0,"shares_owned_after_display":"6,871,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-14","filed_date":"2012-12-19","scope":"insider"},{"id":3462891,"accession":"0000945621-12-000285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000945621-12-000285","line_url":"/filing/0000945621-12-000285#line-1","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249249.0,"shares_display":"249,249","price_per_share":0.9501,"price_display":"0.95","price_state":"stated","total_value":236811.4749,"total_display":"236,811.47","total_whole":"236,811","shares_owned_after":6871981.0,"shares_owned_after_display":"6,871,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-14","filed_date":"2012-12-18","scope":"insider"},{"id":3429680,"accession":"0000945621-12-000282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000945621-12-000282","line_url":"/filing/0000945621-12-000282#line-1","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399414.0,"shares_display":"399,414","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":419384.7,"total_display":"419,384.70","total_whole":"419,385","shares_owned_after":7121230.0,"shares_owned_after_display":"7,121,230","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-12","filed_date":"2012-12-14","scope":"insider"},{"id":3539569,"accession":"0000945621-12-000281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000945621-12-000281","line_url":"/filing/0000945621-12-000281#line-2","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139653.0,"shares_display":"139,653","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":146635.65,"total_display":"146,635.65","total_whole":"146,636","shares_owned_after":7520644.0,"shares_owned_after_display":"7,520,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-10","filed_date":"2012-12-11","scope":"insider"},{"id":3539566,"accession":"0000945621-12-000281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000945621-12-000281","line_url":"/filing/0000945621-12-000281#line-1","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230407.0,"shares_display":"230,407","price_per_share":1.0005,"price_display":"1.00","price_state":"stated","total_value":230522.2035,"total_display":"230,522.20","total_whole":"230,522","shares_owned_after":7660297.0,"shares_owned_after_display":"7,660,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-07","filed_date":"2012-12-11","scope":"insider"},{"id":2065896,"accession":"0000894579-12-000339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000894579-12-000339","line_url":"/filing/0000894579-12-000339#line-2","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":235009.0,"shares_display":"235,009","price_per_share":1.07,"price_display":"1.07","price_state":"stated","total_value":251459.63,"total_display":"251,459.63","total_whole":"251,460","shares_owned_after":7890704.0,"shares_owned_after_display":"7,890,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-06","filed_date":"2012-12-07","scope":"insider"},{"id":2065819,"accession":"0000894579-12-000339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000894579-12-000339","line_url":"/filing/0000894579-12-000339#line-1","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"AUSTIN JOSIAH T; El Coronado Holdings, LLC","owner_display_name":"AUSTIN JOSIAH T","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154836.0,"shares_display":"154,836","price_per_share":1.18,"price_display":"1.18","price_state":"stated","total_value":182706.48,"total_display":"182,706.48","total_whole":"182,706","shares_owned_after":8125713.0,"shares_owned_after_display":"8,125,713","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-05","filed_date":"2012-12-07","scope":"insider"},{"id":3387067,"accession":"0000945621-12-000030","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000945621-12-000030","line_url":"/filing/0000945621-12-000030#line-3","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13900.0,"shares_display":"13,900","price_per_share":4.46,"price_display":"4.46","price_state":"stated","total_value":61994.0,"total_display":"61,994.00","total_whole":"61,994","shares_owned_after":8301049.0,"shares_owned_after_display":"8,301,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-27","filed_date":"2012-01-30","scope":"insider"},{"id":3387063,"accession":"0000945621-12-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000945621-12-000030","line_url":"/filing/0000945621-12-000030#line-2","is_derivative":false,"issuer_cik":"0000932267","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0000932267","owner_cik":null,"owner_name":"El Coronado Holdings, LLC; AUSTIN JOSIAH T","owner_display_name":"El Coronado Holdings, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":4.5019,"price_display":"4.50","price_state":"stated","total_value":18007.6,"total_display":"18,007.60","total_whole":"18,008","shares_owned_after":8305049.0,"shares_owned_after_display":"8,305,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-27","filed_date":"2012-01-30","scope":"insider"}],"collapsed":true,"next_cursor":"2012-01-27|3387063","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001335103","name":"Protea Biosciences Group, Inc.","url":"/issuer/0001335103","role":"Ten percent owner","n_filings":5,"first_seen":"2013-03-25","last_seen":"2014-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001075880","name":"NOVOGEN LTD","url":"/issuer/0001075880","role":"Ten percent owner","n_filings":57,"first_seen":"2006-05-11","last_seen":"2013-11-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001333763","name":"Chelsea Therapeutics International, Ltd.","url":"/issuer/0001333763","role":"Ten percent owner","n_filings":99,"first_seen":"2007-04-02","last_seen":"2012-12-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001088213","name":"Nano Mask, Inc.","url":"/issuer/0001088213","role":"Ten percent owner","n_filings":18,"first_seen":"2005-03-04","last_seen":"2009-06-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001319763","retrieved_at":"2026-08-26T05:57:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}